Mr. Rush (for himself, Mr. Casten, Mr. Cohen, Mr. Connolly, Mr. DeSaulnier, Mr. Neguse, Mr. Ruiz, Ms. Underwood, and Mr. Van Drew) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.
Sean Casten
(IL); Steve Cohen
(TN); Gerald E. Connolly
(VA); Mark DeSaulnier
(CA); Joe Neguse
(CO); Raul Ruiz
(CA); Lauren Underwood
(IL); Jefferson Van Drew
(NJ)
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Protecting Consumer Access to Generic Drugs Act of 2021. H.R. 153. 117th
Cong., 1st
sess., Introduced in House January 4, 2021. https://www.govinfo.gov/app/details/BILLS-117hr153ih.
APA
Congress, House of Representatives (2021, January 4). Protecting Consumer Access to Generic Drugs Act of 2021 (H.R. 153 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-117hr153ih.
MLA
United States, Congress, House of Representatives. Protecting Consumer Access to Generic Drugs Act of 2021. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-117hr153ih. 117th Congress, H.R. 153, Introduced in House 4 Jan. 2021.
Bluebook
H.R.153 - 117th Congress (2021-2022): Protecting Consumer Access to Generic Drugs Act of 2021, H.R.153, 117th Cong. (2021), https://www.govinfo.gov/app/details/BILLS-117hr153ih.
